In the treatment of renal cell carcinoma and soft tissue sarcoma, the Votrient drug has proven itself well. This is a thyroxine kinase inhibiting drug, an enzyme responsible for the growth of blood vessels. As a result, a malignant neoplasm of the soft tissues does not grow, the tumor does not progress.
The active substance "Votrient" is pazopanib hydrochloride. Auxiliary components are magnesium stearate, sodium carboxymethyl starch, povidone K30 and microcrystalline cellulose.
Generic "Votrient" - what is it?
The original product is produced in the UK and Spain, and its cost ranges from 60 to 80 thousand rubles, if it comes to packing tablets (60 pieces) with a dosage of 200 mg, or from 80 to 120 thousand, if it is 60 tablets, each which contains 400 mg of the main component. This variation in price is explained by the difference in prices in pharmacies in Moscow and regions of the Russian Federation. And yet, even the sum of 60,000 rubles is palpable for many or almost unbearable.
However buy possible for less money. Indian representative of GlaxoSmithKline PLC. sells pazopanib in the domestic market at a price of 50,000 rubles or less. The difference in price is significant, but this does not mean that quality suffers. The drug made in India is cheaper, because for the farm. India distributors have special prices. The Votrient is manufactured by an Indian manufacturer under an official license. This means that it meets existing quality and safety standards. Indian drug Votrient is receiving positive reviews from patients with renal cell carcinoma and sarcoma from around the world. They note that the growth of neoplasms is suspended, and the general condition is improving.
Where to buy Votrient at a price that is not shocking?
In order to purchase a generic, you will not need to look for the drug in the pharmacy chains of the city. You don’t even have to go to the pharmacy. You can get the medicine on the site of an Indian company with five years of successful experience . As already mentioned above, the price for Votrient in this case will be lower than for the original British or Spanish product, and will be approximately 28,000 rubles per pack of 60 tablets in a dosage of 200 mg and 50,000 per unit, in one tablet which contains 400 mg of pazopanib hydrochloride.
The condition for the provision of services is the availability of relevant documents that can confirm the need for modern treatment.
How to use the tool: dosage
Before using Votrient, consult your healthcare provider. The recommended dosage of the drug is 800 mg per day at a time. At the same time, try not to damage the outer shell of the tablet, i.e., it is forbidden to crack or break it.
Votrient should be applied at approximately the same time. If you missed the next dose and less than 12 hours are left until the next, then it is not recommended to replenish the missed dose.
Contraindications
Votrient is contraindicated in the following categories of patients:
- having a severe degree of hepatic or renal failure;
- pregnant women and nursing mothers;
- children under 2 years old;
- persons with hypersensitivity to the components of the drug.
special instructions
With extreme caution, Votrient should be given to the following categories of patients:
- with mild to moderate liver failure;
- suffering from thrombosis or other diseases of the cardiovascular system;
- with gastrointestinal diseases.
In addition, in patients with thyroid problems, it is necessary to monitor the functional state of the organ when taking the described drug.
Before any kind of surgical intervention, the Votrient preparation should be stopped for a week, since the main active substance affects the speed of wound healing.
Interaction with other drugs
Votrient is not used in conjunction with other antitumor drugs (such as Lapatinib, Pemetrexed, etc.).